Fundraising FoxBeacon Angels — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients.
BiotechDigital HealthFemTechHealthtechMedical DevicesPleasanton, US
Nancy Schoenbrunner(Chief Executive Officer)inShoulian Dong(Chief Scientific Officer)Daniel Schoener(Chief Product Officer)inChris Meda(Chief Commercial Officer)inMing Tan(Director)Sammy Datwani(Director)
Co-investorsAvestria VenturesSocial StartsShepherd Ventures
Lenoss develops products aimed at advancing a physiological treatment pathway, supported by a team of industry professionals and clinical advisors.
BiotechHealthtechMedical DevicesProvidence, US
Dom Messerli, MBAinDominique Messerli(Executive Officer, Director)
Co-investorsAZ Venture Capital Inc.Slater Technology FundWalnut Venture AssociatesXcellerant Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.